Ampa
Latest round
- Seed
Last raised
- Oct 2025
Total raised
- $8.5M
Investors
- 5
About Ampa
, based in the US, specializes in brain-stimulation technologies designed to enhance mental health treatment, offering innovative solutions that target resilience and emotional strength through advanced Transcranial Magnetic Stimulation techniques. Founded in 2022 in Palo Alto, US, by Jonathan Downar and Don Vaughn (CEO), Ampa Inc. develops brain-stimulation solutions to improve mental health outcomes. Ampa has no known subsidiaries or parent companies and does not appear to have undergone significant pivots in its business strategy since inception. Ampa specializes in advanced Transcranial Magnetic Stimulation (TMS) technology, specifically through its flagship product, the Ampa One system. This innovative platform is designed to enhance brain circuits related to resilience and inner strength, aiming to alleviate symptoms associated with depression and other mental health disorders. The Ampa One system is characterized by its user-friendly, lightweight design, making it suitable for clinical applications. Clinicians utilize this technology to provide effective, non-invasive treatment options for patients, contributing to higher remission rates compared to traditional TMS solutions. Ampa's services are primarily targeted at healthcare providers and mental health professionals across various geographical markets, including the United States, where the demand for accessible mental health care solutions continues to grow.Ampa’s revenue model is primarily based on the sale of its TMS technology, with the Ampa One system being a key income generator. The company engages in direct sales to healthcare providers, enabling them to incorporate TMS therapy into their treatment offerings. Transactions typically involve one-time purchases of the Ampa One system along with ongoing service agreements that may include maintenance and support. Ampa also facilitates partnerships with insurers to cover TMS therapy, ensuring that patients can access the treatment without prohibitive out-of-pocket costs. The company's pricing structure reflects the high value of its technology and services, catering to both B2B transactions with healthcare facilities and direct consumer engagement through partnerships. By addressing a crucial need in the mental health sector, Ampa positions itself to expand its influence on patient care and outcomes. In May 2026, Ampa Inc.
Who invested in Ampa
5 investors across 1 round
See all investors in Ampa
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 22, 2025
Amount
$8.5M
Investors
Questions about Ampa
Who invested in Ampa?
Ampa has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ampa raised?
Ampa has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ampa last raise money?
Ampa's most recent round on record is a Seed, in Oct 2025.
What does Ampa do?
, based in the US, specializes in brain-stimulation technologies designed to enhance mental health treatment, offering innovative solutions that target resilience and emotional strength through advanced Transcranial Magnetic Stimulation techniques.
Where is Ampa headquartered?
Ampa is headquartered in San Diego, US.
Which VCs invest in companies like Ampa?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Ampa's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Ampa? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.